Role of Novel Dietary Supplement N-acetyl Cysteine in Treating Negative Symptoms in Schizophrenia: A 6-Month Follow-up Study

BACKGROUND: Abnormal metabolism of dopamine and glutamate in schizophrenia induces oxidative stress that is exacerbated by brain glutathione (GSH) deficiency. N-acetyl cysteine (NAC) increases brain GSH levels and is being used as an adjunctive agent in patients with schizophrenia. This open-label e...

Descripción completa

Detalles Bibliográficos
Autores principales: Tharoor, Hema, Mara, Sindhu, Gopal, Subhashini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009003/
https://www.ncbi.nlm.nih.gov/pubmed/29962570
http://dx.doi.org/10.4103/IJPSYM.IJPSYM_322_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009003/
https://www.ncbi.nlm.nih.gov/pubmed/29962570
http://dx.doi.org/10.4103/IJPSYM.IJPSYM_322_17

Ejemplares similares